C Lorenzo1, K Williams, S M Haffner. 1. Division of Clinical Epidemiology, University of Texas Health Science Center KenAnCo Biostatistics San Antonio, Texas 78229, USA. lorenzo@uthscsa.edu
Abstract
AIMS: The Insulinogenic Index from 0 to 30 min (ΔI (0-30) /ΔG(0-30) ), a measure of insulin secretion derived from the early period of the oral glucose tolerance test, predicts future diabetes. However, there are few data on secretory measures from the late oral glucose tolerance test period. We therefore investigated the association of the ratio of the area under the insulin curve to the area under the glucose curve from 60 to 120 min (I/G(AUC 60-120) ) with incident diabetes. METHODS: Participants were 1540 Mexican Americans and non-Hispanic whites in the San Antonio Heart Study who were free of diabetes at baseline. We analysed indices of sensitivity (Matsuda index) and secretion from the early (ΔI(0-30) /ΔG(0-30) ) and late oral glucose tolerance test periods (I/G(AUC 60-120) ). RESULTS: A total of 179 participants developed diabetes after 7.5 years. I/G(AUC 60-120) was an independent predictor of diabetes [odds ratio × 1 SD unit increase, 0.37 (0.26-0.54)] in a model that also included age, sex, ethnicity, body mass index, family history of diabetes, Matsuda index and (ΔI (0-30) /ΔG(0-30) ) as covariates. I/G(AUC 60-120) increased the C statistic (a test of discrimination) of the model (0.882 vs. 0.875, P=0.044). I/G(AUC 60-120) correctly reclassified one-fifth of individuals with moderate and strong risks of future diabetes. The net reclassification improvement was 0.13 (P<0.001) and the integrated discrimination improvement was 0.033 (P<0.001). CONCLUSIONS: An insulin secretory measure derived from the late oral glucose tolerance test period is useful for classifying individuals at risk of future diabetes independently of other risk factors, including insulin sensitivity and a secretory measure from the early oral glucose tolerance test period.
AIMS: The Insulinogenic Index from 0 to 30 min (ΔI (0-30) /ΔG(0-30) ), a measure of insulin secretion derived from the early period of the oral glucose tolerance test, predicts future diabetes. However, there are few data on secretory measures from the late oral glucose tolerance test period. We therefore investigated the association of the ratio of the area under the insulin curve to the area under the glucose curve from 60 to 120 min (I/G(AUC 60-120) ) with incident diabetes. METHODS:Participants were 1540 Mexican Americans and non-Hispanic whites in the San Antonio Heart Study who were free of diabetes at baseline. We analysed indices of sensitivity (Matsuda index) and secretion from the early (ΔI(0-30) /ΔG(0-30) ) and late oral glucose tolerance test periods (I/G(AUC 60-120) ). RESULTS: A total of 179 participants developed diabetes after 7.5 years. I/G(AUC 60-120) was an independent predictor of diabetes [odds ratio × 1 SD unit increase, 0.37 (0.26-0.54)] in a model that also included age, sex, ethnicity, body mass index, family history of diabetes, Matsuda index and (ΔI (0-30) /ΔG(0-30) ) as covariates. I/G(AUC 60-120) increased the C statistic (a test of discrimination) of the model (0.882 vs. 0.875, P=0.044). I/G(AUC 60-120) correctly reclassified one-fifth of individuals with moderate and strong risks of future diabetes. The net reclassification improvement was 0.13 (P<0.001) and the integrated discrimination improvement was 0.033 (P<0.001). CONCLUSIONS: An insulin secretory measure derived from the late oral glucose tolerance test period is useful for classifying individuals at risk of future diabetes independently of other risk factors, including insulin sensitivity and a secretory measure from the early oral glucose tolerance test period.
Authors: M Stumvoll; A Mitrakou; W Pimenta; T Jenssen; H Yki-Järvinen; T Van Haeften; W Renn; J Gerich Journal: Diabetes Care Date: 2000-03 Impact factor: 19.112
Authors: Carlos Lorenzo; Lynne E Wagenknecht; Marian J Rewers; Andrew J Karter; Richard N Bergman; Anthony J G Hanley; Steven M Haffner Journal: Diabetes Care Date: 2010-09 Impact factor: 17.152
Authors: Yong Zhang; Jie Sun; Feng Li; Tristan R Grogan; Jose L Vergara; QingXian Luan; Moon-Soo Park; David Chia; David Elashoff; Kaumudi J Joshipura; David T W Wong Journal: Diabetes Res Clin Pract Date: 2017-07-19 Impact factor: 5.602
Authors: Kristina M Utzschneider; Naji Younes; Neda Rasouli; Joshua Barzilay; Mary Ann Banerji; Robert M Cohen; Erica V Gonzalez; Kieren J Mather; Faramarz Ismail-Beigi; Philip Raskin; Deborah J Wexler; John M Lachin; Steven E Kahn Journal: J Diabetes Complications Date: 2021-03-17 Impact factor: 2.852
Authors: Latife Bozkurt; Christian S Göbl; Karoline Leitner; Giovanni Pacini; Alexandra Kautzky-Willer Journal: BMJ Open Diabetes Res Care Date: 2020-11
Authors: Christian S Göbl; Johannes Ott; Latife Bozkurt; Michael Feichtinger; Victoria Rehmann; Anna Cserjan; Maike Heinisch; Helmut Steinbrecher; Ivica JustKukurova; Radka Tuskova; Michael Leutner; Elisabeth Vytiska-Binstorfer; Christine Kurz; Andrea Weghofer; Andrea Tura; Christian Egarter; Alexandra Kautzky-Willer Journal: PLoS One Date: 2016-08-09 Impact factor: 3.240